Josef Vágner

3.9k total citations
97 papers, 3.1k citations indexed

About

Josef Vágner is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Josef Vágner has authored 97 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Josef Vágner's work include Chemical Synthesis and Analysis (35 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (19 papers). Josef Vágner is often cited by papers focused on Chemical Synthesis and Analysis (35 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (19 papers). Josef Vágner collaborates with scholars based in United States, Czechia and Norway. Josef Vágner's co-authors include Victor J. Hruby, Hongchang Qu, Viktor Krchňák, Robert J. Gillies, Heather L. Handl, Eugene A. Mash, David L. Morse, Michal Lebl, Theodore J. Price and J.S. Josan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Josef Vágner

95 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josef Vágner United States 32 2.0k 794 485 380 326 97 3.1k
Gunnar Lindeberg Sweden 30 1.4k 0.7× 632 0.8× 352 0.7× 497 1.3× 346 1.1× 89 2.7k
Hyun‐Woo Rhee South Korea 29 2.9k 1.4× 903 1.1× 181 0.4× 198 0.5× 215 0.7× 82 4.5k
Angela N. Koehler United States 30 3.1k 1.6× 714 0.9× 647 1.3× 255 0.7× 415 1.3× 59 4.1k
Jianming Xie United States 30 2.6k 1.3× 685 0.9× 346 0.7× 412 1.1× 517 1.6× 51 4.4k
Gábor Mező Hungary 29 1.9k 0.9× 651 0.8× 489 1.0× 121 0.3× 560 1.7× 160 2.9k
Pavel Majer Czechia 31 1.6k 0.8× 565 0.7× 418 0.9× 377 1.0× 640 2.0× 117 3.3k
Günther Bernhardt Germany 32 2.0k 1.0× 754 0.9× 180 0.4× 769 2.0× 1.2k 3.6× 143 3.8k
Steven Ballet Belgium 30 1.8k 0.9× 761 1.0× 298 0.6× 842 2.2× 220 0.7× 167 2.7k
Gene M. Dubowchik United States 26 1.3k 0.6× 709 0.9× 596 1.2× 173 0.5× 719 2.2× 80 3.0k
Motonari Uesugi Japan 34 2.4k 1.2× 708 0.9× 135 0.3× 186 0.5× 431 1.3× 131 3.6k

Countries citing papers authored by Josef Vágner

Since Specialization
Citations

This map shows the geographic impact of Josef Vágner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Vágner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Vágner more than expected).

Fields of papers citing papers by Josef Vágner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Vágner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Vágner. The network helps show where Josef Vágner may publish in the future.

Co-authorship network of co-authors of Josef Vágner

This figure shows the co-authorship network connecting the top 25 collaborators of Josef Vágner. A scholar is included among the top collaborators of Josef Vágner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Vágner. Josef Vágner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Ayesha, Kathryn DeFea, Josef Vágner, et al.. (2023). Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice. Journal of Pain. 24(11). 1980–1993. 8 indexed citations
2.
Mason, Bianca N., Shayne Hassler, Kathryn DeFea, et al.. (2023). PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model. The Journal of Headache and Pain. 24(1). 42–42. 11 indexed citations
3.
Ahmad, Ayesha, Stephanie Shiers, Michael D. Burton, et al.. (2022). C781, a β-Arrestin Biased Antagonist at Protease-Activated Receptor-2 (PAR2), Displays in vivo Efficacy Against Protease-Induced Pain in Mice. Journal of Pain. 24(4). 605–616. 6 indexed citations
4.
Mwirigi, Juliet M., Shayne Hassler, Ayesha Ahmad, et al.. (2021). A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist. Journal of Pain. 22(6). 692–706. 9 indexed citations
5.
Hassler, Shayne, Juliet M. Mwirigi, Ayesha Ahmad, et al.. (2020). The cellular basis of protease activated receptor type 2 (PAR2) evoked mechanical and affective pain. JCI Insight. 5(11). 16 indexed citations
6.
Weterings, Eric, Alfred Gallegos, Laurence Cooke, et al.. (2016). A novel small molecule inhibitor of the DNA repair protein Ku70/80. DNA repair. 43. 98–106. 58 indexed citations
7.
Baker, Robert, Babak Amirsolaimani, Soroush Mehravar, et al.. (2016). Imaging of targeted lipid microbubbles to detect cancer cells using third harmonic generation microscopy. Biomedical Optics Express. 7(7). 2849–2849. 25 indexed citations
8.
Anderson, Miranda J., et al.. (2015). A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas. Molecular Imaging and Biology. 17(4). 461–470. 3 indexed citations
9.
Boitano, Scott, Justin Hoffman, Dipti V. Tillu, et al.. (2014). Development and Evaluation of Small Peptidomimetic Ligands to Protease-Activated Receptor-2 (PAR2) through the Use of Lipid Tethering. PLoS ONE. 9(6). e99140–e99140. 16 indexed citations
10.
Hart, Nathaniel, Woo Jin Chung, Craig Weber, et al.. (2013). Hetero‐bivalent GLP‐1/Glibenclamide for Targeting Pancreatic β‐Cells. ChemBioChem. 15(1). 135–145. 4 indexed citations
11.
Tafreshi, Narges K., Xuan‐Yi Huang, Vernon K. Sondak, et al.. (2012). Synthesis and Characterization of a Melanoma-Targeted Fluorescence Imaging Probe by Conjugation of a Melanocortin 1 Receptor (MC1R) Specific Ligand. Bioconjugate Chemistry. 23(12). 2451–2459. 31 indexed citations
12.
Tafreshi, Narges K., Marilyn M. Bui, Mark C. Lloyd, et al.. (2011). Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes. Clinical Cancer Research. 18(1). 207–219. 69 indexed citations
13.
Josan, J.S., Channa R. De Silva, Byunghee Yoo, et al.. (2011). Fluorescent and Lanthanide Labeling for Ligand Screens, Assays, and Imaging. Methods in molecular biology. 716. 89–126. 21 indexed citations
14.
Tafreshi, Narges K., Steven A. Enkemann, Marilyn M. Bui, et al.. (2010). A Mammaglobin-A Targeting Agent for Noninvasive Detection of Breast Cancer Metastasis in Lymph Nodes. Cancer Research. 71(3). 1050–1059. 45 indexed citations
15.
Xu, Liping, Josef Vágner, Bhumasamudram Jagadish, et al.. (2010). Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors. Bioorganic & Medicinal Chemistry Letters. 20(8). 2489–2492. 8 indexed citations
16.
Xu, Liping, Josef Vágner, J.S. Josan, et al.. (2009). Enhanced targeting with heterobivalent ligands. Molecular Cancer Therapeutics. 8(8). 2356–2365. 46 indexed citations
17.
Vágner, Josef, Hongchang Qu, & Victor J. Hruby. (2008). Peptidomimetics, a synthetic tool of drug discovery. Current Opinion in Chemical Biology. 12(3). 292–296. 437 indexed citations
18.
Vágner, Josef, Liping Xu, Heather L. Handl, et al.. (2008). Heterobivalent Ligands Crosslink Multiple Cell‐Surface Receptors: The Human Melanocortin‐4 and δ‐Opioid Receptors. Angewandte Chemie International Edition. 47(9). 1685–1688. 62 indexed citations
19.
Handl, Heather L., Josef Vágner, Haiyong Han, et al.. (2004). Hitting multiple targets with multimeric ligands. Expert Opinion on Therapeutic Targets. 8(6). 565–586. 93 indexed citations
20.
Krchňák, Viktor, et al.. (1993). Aggregation of resin‐bound peptides during solid‐phase peptide synthesis. International journal of peptide & protein research. 42(5). 450–454. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gunnar Lindeberg Breakdown of academic impact, for papers by Hyun‐Woo Rhee Breakdown of academic impact, for papers by Angela N. Koehler Breakdown of academic impact, for papers by Jianming Xie Breakdown of academic impact, for papers by Gábor Mező Breakdown of academic impact, for papers by Pavel Majer Breakdown of academic impact, for papers by Günther Bernhardt Breakdown of academic impact, for papers by Steven Ballet Breakdown of academic impact, for papers by Gene M. Dubowchik Breakdown of academic impact, for papers by Motonari Uesugi
Rankless by CCL
2026